Next Generation iBOT— 510(k) K172601

Substantially Equivalent

Deka Research & Development Corp.

FDA 510(k) clearance K172601 for Next Generation iBOT, Substantially Equivalent on 2018-03-02. Applicant: Deka Research & Development Corp..

Clearance details

Applicant: Deka Research & Development Corp.
Product code: Code IMK
Advisory panel: Physical Medicine
Date received: 2017-08-30
Decision date: 2018-03-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Manchester, NH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.